Fatema Tuz Zohora

Dr. Fatema Tuz Zohora

University of Asia Pacific, Dhaka, Bangladesh
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
KNKamrun Nahar
Kamrun Nahar
FZFatema Tuz Zohora
Fatema Tuz Zohora
RBRayhana Begum
Rayhana Begum
MHMaruf Hasan
Maruf Hasan
AAAbdul Aziz
Abdul Aziz
RARafi Anwar
Rafi Anwar
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.

24 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
FZFatema Tuz Zohora
Fatema Tuz Zohora
FZFatema Tuz Zohora
Fatema Tuz Zohora
SASinthyia Ahmed
Sinthyia Ahmed
Khondaker Miraz RahmanKhondaker Miraz Rahman
Khondaker Miraz Rahman
MHMohammad Halim
Mohammad Halim
SASania Ashrafi
Sania Ashrafi
A new dimeric prenylated quinolone alkaloid, named 2,11-didemethoxy-vepridimerine A, was isolated from the root bark of Zanthoxylum rhetsa, together with twelve known compounds. The structure of the new compound was elucidated on the basis of spectroscopic investigations (NMR and Mass). The interaction of the isolated compounds with the main protease of SARS-CoV-2 (Mpro) was evaluated using molecular docking followed by MD simulations. The result suggests that 2,11-didemethoxy-vepridimerine A, the new compound, has the highest negative binding affinity against the Mpro with a free energy of binding of −8.5 Kcal/mol, indicating interaction with the Mpro. This interaction was further validated by 100 ns MD simulation. This implies that the isolated new compound, which can be employed as a lead compound for an Mpro-targeting drug discovery program, may be able to block the action of Mpro.

6 October 2025 in Health Science Reports
Verified
Journal Article
Open access
ZAZubaier Ahmed
Zubaier Ahmed
KPKazi Milenur Rahman Prattay
Kazi Milenur Rahman Prattay
SSsabrina sharmin
sabrina sharmin
FZFatema Tuz Zohora
Fatema Tuz Zohora
ARAsef Raj
Asef Raj
EAElias Al‐Mamun
Elias Al‐Mamun
Background and Aims: Following the end of the COVID‐19 global emergency, concern has shifted to “Disease X,” a hypothetical, highly transmissible, and deadly pathogen, and Middle East Respiratory Syndrome Coronavirus (MERS‐CoV) is a prime candidate for this. This review explores its epidemiology, mutations, transmission, and potential to become a pandemic‐capable pathogen, aiming to support future research and public health preparedness against the disease. Methods: A comprehensive search of major databases was conducted for peer‐reviewed English articles (2000–2025) focusing on virology, outbreaks, treatments, and public health using relevant but definite keywords. Studies met strict inclusion criteria and standardized methods to ensure quality, reproducibility, and transparency. Results: Since it was identified in 2012, MERS‐CoV has spread across 27 countries, presenting a high case fatality rate (~34.5%) and zoonotic origin. It is primarily linked to dromedary camels, but shows limited human‐to‐human transmission ( R ₀ < 1). Unlike SARS‐CoV‐2, MERS‐CoV's spread is confined to close contact and healthcare settings, largely in the Middle East and parts of Africa. Its pathogenesis involves severe respiratory illness, driven by immune evasion and systemic inflammation, especially in individuals with comorbidities. While MERS‐CoV lacks pandemic‐level transmissibility, its genetic plasticity poses a risk for future evolution. Vaccine and therapeutic development remain limited due to sporadic outbreaks and low global urgency. Conclusion: Despite not currently fitting the Disease X archetype, MERS‐CoV's high mortality, zoonotic spillover potential, and possibility for increased transmissibility warrant continued surveillance, targeted research, and strengthened public health infrastructure to prevent localized outbreaks from escalating into broader crises.

15 December 2023 in Trends in Immunotherapy
Verified
Journal Article
Open access
PDF file
FZFatema Tuz Zohora
Fatema Tuz Zohora
IJIrin Sultana Joya
Irin Sultana Joya
MBMohiuddin Ahmed Bhuiyan
Mohiuddin Ahmed Bhuiyan
CHChoudhury Mahmood Hasan
Choudhury Mahmood Hasan
MAMonira Ahsan
Monira Ahsan
Studies conducted on the chemical composition of the genus Trichilia have isolated and identified 334 different compounds such as monoterpenes, diterpenes, sesquiterpenes, triterpenes, limonoids, steroids, coumarins, lignans, flavonoids, amino acid, phenolic acids, and lactones. This genus is used in traditional medicine for the manufacture of antibacterial, antioxidant, antiviral and antimalarial drugs. Indeed, our research with numerous Trichilia species has revealed that these plants exhibit antioxidant, antibacterial, anticholinesterase, neuroprotective, anti-inflammatory, and anti-anaphylactic properties against pathogens of major clinical value. The properties of analgesia, liver protection, and immunomodulation are also being studied. This study summarizes the main therapeutic uses of Genus Trichilia of species mentioned in the article and encourages future research into their usage in the treatment of various ailments as antimicrobial and anticancer.

30 June 2023 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
NJNisrat Jahan
Nisrat Jahan
KSKhozirah Shaari
Khozirah Shaari
SISk Nazrul Islam
Sk Nazrul Islam
AAAtm Zafrul Azam
Atm Zafrul Azam
FZFatema Tuz Zohora
Fatema Tuz Zohora
MAMonira Ahsan
Monira Ahsan
The study's objectives include phytochemical profiling and biological (antioxidant, thrombolytic and cytotoxic) analysis of pure chemicals from Jatropha pandurifolia stem bark ethyl acetate extract. Five different compounds including octacosanyl cis ferulate (1), hexacosyl (E)-ferulate (2) triacontyl ferulate (3), β-sitosterol (4) and stigmasterol (5) are elucidated. Their structures determine through 1HNMR analysis and comparison to published data, while three ferulic acid alkyl esters (1-3) were isolated for the first time from J. pandurifolia. Compounds 1, 2, and 3 all have significant thrombolytic potential with respective values of 68.92% ±1.17 (**P<0.01), 66.56% ±2.35 (**P<0.01) and 70.81%±0.98 (**P<0.01) with comparison to standard streptokinase (73.6%±0.76). When compared to BHT (6.82± 0.99 μg/ml) the IC50 (DPPH assay) values were 16.26±1.07 (**P<0.01), 14.12±1.23 (**P<0.01), and 13.16±1.70 μg/ml (**P<0.01). Comparing the three compounds to the reference vincristine sulphate (LC50: 0.52±0.18 μg/ml), of compound 1 (1.56±0.35 μg/ml) (**P<0.01), compound 2 (1.3±0.78 μg/ml) (**P<0.01) and compound 3 (1.29±0.33 μg/ml) (**P<0.01). The results can therefore be interpreted as a concept of isolated molecules having potential for application in additional pharmaceutical research.

11 July 2024 in Heliyon
Verified
Journal Article
Open access
FTFatema Tabassum
Fatema Tabassum
SISheikh Nazrul Islam
Sheikh Nazrul Islam
FZFatema Tuz Zohora
Fatema Tuz Zohora
CHChoudhury Mahmood Hasan
Choudhury Mahmood Hasan
KRKhondaker Miraz Rahman
Khondaker Miraz Rahman
MAMonira Ahsan
Monira Ahsan
A new 2-quinolone alkaloid, iso-oligophyline (1), and two very unusual C34 terpenoids, proposed names ravespanol (2) and ravespanone (3), along with two known compounds, β-sitosterol (4), and methyl linoleate (5), were isolated from the leaf extract of Ravenia spectabilis engl. Methyl linoleate constitutes the first report of isolation from this species. We have already reported the isolation of atanine (6), oligophyline (7), ravenoline (8), and arborinine (9) from the plant. Based on nuclear magnetic resonance (NMR) spectroscopy and mass spectrometric analysis, the structure of the isolated chemicals was determined. The crude fractions and four compounds (6,7,8 and 9) were evaluated for a cytotoxicity study on a panel of six human stomach cancer cell lines (SCL, SCL-6, SCL-37'6, SCL-9, K-3, N21) by MTT assay. Among the plant extracts and isolated compounds, petroleum ether fraction and compound 7 exhibited the highest cytotoxic activity against SCL and SCL-6 cells, where the IC50 values were 17.9 and 16.56 μM, respectively.